Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 4/1999

Content (12 Articles)

ORIGINAL ARTICLE

Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts

Jill P. Smith, Sarathchandra Kanekal, Montesa B. Patawaran, Joy Y. Chen, Richard E. Jones, Elaine K. Orenberg, Ning Y. Yu

ORIGINAL ARTICLE

Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIα and β

Rosalind M. Turnbull, Emma L. Meczes, M. Perenna Rogers, Richard B. Lock, Daniel M. Sullivan, Graeme J. Finlay, Bruce C. Baguley, Caroline A. Austin

ORIGINAL ARTICLE

Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent

Merrill J. Egorin, Eleanor G. Zuhowski, Dorothy L. Sentz, Jason M. Dobson, Patrick S. Callery, Julie L. Eiseman

ORIGINAL ARTICLE

Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer

Françoise Bressolle, Jean M. Joulia, Frédéric Pinguet, Marc Ychou, Cécile Astre, Jacqueline Duffour, Roberto Gomeni

ORIGINAL ARTICLE

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

A. M. Lopez, L. Wallace, R. T. Dorr, M. Koff, E. M. Hersh, D. S. Alberts

ORIGINAL ARTICLE

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

Tony S. K. Mok, Thomas W. T. Leung, Shou-Dong Lee, Yee Chao, Anthony T. C. Chan, Andrew Huang, Mei-Ching Lui, Winnie Yeo, Karen Chak, Amanda Johnston, Philip Johnson

ORIGINAL ARTICLE

Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays

Albert A. Geldof, Simon C. Mastbergen, Roland E. C. Henrar, Glynn T. Faircloth

ORIGINAL ARTICLE

Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N -dechloroethylation of trofosfamide

Antje May-Manke, Heyo Kroemer, Georg Hempel, Frank Bohnenstengel, Barbara Hohenlöchter, Gottfried Blaschke, Joachim Boos

ORIGINAL ARTICLE

Regional heterogeneity and pharmacodynamics in human solid tumor histoculture

Jean R. Weaver, M. Guillaume Wientjes, Jessie L.-S. Au

SHORT COMMUNICATION

Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours

Vinodh R. Nannan Panday, Ronald de Wit, Jan H. Schornagel, Margaret Schot, Hilde Rosing, Jan Lieverst, Wim W. ten Bokkel Huinink, Jan H. M. Schellens, Jos H. Beijnen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine